Avantium N.V (AVTXF) Fair Value & Analysis
Basic Materials · US · Market cap $214M
Fair value as of: Jun 25, 2026
Analysis
Avantium N.V (AVTXF) currently trades at $8.47, while our model-based Fair Value estimate is $47.94 — implying the stock looks roughly 466.0% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Avantium N.V., a chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands. It operates through Avantium R&D Solutions and Avantium Renewable Polymers. The company offers Releaf, boasts barrier properties for carbon dioxide and oxygen that leads to longer shelf life of packaged products used for packaging, textiles, film, and PEF applications. It also provides furandicarboxylic acid (FDCA), a building block for the high-performance plant-based polymer polyethylene furanoate (PEF). In addition, the company offers YXY Technology which catalytically converts plant-based sugars into FDCA. Further, it is development and commercialization of the Dawn Technology, Parana Technology, and Volta Technology. The company was founded in 2000 and is headquartered in Amsterdam, the Netherlands.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Avantium N.V (AVTXF) undervalued?
What is the fair value of AVTXF?
What is the quality score of AVTXF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.